Recent News

By Category: Biotechnology

Pakistan Continues To Face Challenges In Polio Eradication Efforts

In her blog, Maryn McKenna, a journalist and senior fellow of the Schuster Institute at Brandeis University, discusses the challenges of eliminating polio in Pakistan and “the possibility of [the disease] surging back over the rest of the world.”

Genetic Changes in Ebola Could Impede Countermeasures

Scientists studying the genetic makeup of the Ebola virus currently circulating in West Africa have identified several mutations that could have implications for developing effective drugs to fight the virus. Their findings, published in mBio, the online open-access journal of the American Society for Microbiology, identified changes in the current West African outbreak strain that  Read More »

Biological safety lock for genetically modified organisms

Scientists have genetically recoded a strain of E. coli to depend on a synthetic amino acid so the bacteria can’t survive outside the lab. The E. coli were also made resistant to two viruses.

J&J Announce Start of Phase 1 Clinical Trial of Ebola Vaccine

Johnson & Johnson this week announced the start of a Phase 1, first-in-human clinical trial of a preventive Ebola vaccine in development at its Janssen Pharmaceutical Companies. The trial is being led by the Oxford Vaccine Group, part of the University of Oxford Department of Paediatrics. Recruitment in the trial is underway, and the first  Read More »

UC Davis Working to Help Speed Ebola Drug Production

Researchers at the University of California, Davis will explore ways to speed production of the Ebola drug with a $200,000 rapid-response grant from the National Science Foundation. Developed by Mapp Biopharmaceutical Inc. of San Diego, in collaboration with the U.S. government and partners in Canada, Zmapp is a cocktail of antibodies produced in and extracted  Read More »

« First...23456...102030...Last »

Also filed under "Biotechnology":